LOC646736 inhibitors represent a specialized category of chemical agents that are specifically designed to target and inhibit the function of the biomolecule denoted as LOC646736. This molecular target is implicated in a particular cellular or biochemical pathway and plays a pivotal role in its regulation. The inhibitors in this class are crafted to bind to LOC646736 with high specificity, thereby blocking its activity. The nature of the inhibition can vary; some inhibitors may block the active site directly, preventing substrate interaction, while others may bind to allosteric sites, inducing conformational changes that result in the loss of enzymatic activity. The molecular design of LOC646736 inhibitors is a sophisticated process that requires a nuanced understanding of the target's structure and the dynamic nature of its interactions within the cell.
The discovery and optimization of LOC646736 inhibitors typically begin with a robust characterization of the target molecule. Techniques such as X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy can provide detailed insights into the three-dimensional structure of LOC646736. With structural data in hand, chemists and biologists use a combination of empirical and computational approaches to identify potential binding sites and to design molecules that can interact with these sites effectively. The structure-activity relationship (SAR) is a critical concept in the development of these inhibitors, guiding chemists in modifying various chemical groups to improve binding affinity and specificity. Computer-aided drug design (CADD) often plays a key role, allowing for the virtual screening of large libraries of compounds and the simulation of their interactions with LOC646736. Through iterative rounds of design, synthesis, and testing, the chemical structures of these inhibitors are refined to maximize their ability to interact with the target molecule in a precise and controlled manner. This ensures that the final compounds are not only potent inhibitors of LOC646736 but also possess the necessary properties for stability and selectivity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thereby potentially reducing protein expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Puromycin causes premature chain termination during protein synthesis by acting as an analog to aminoacyl-tRNA, which could lead to the inhibition of protein expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin inhibits eukaryotic protein synthesis by interfering with peptide chain elongation, which can reduce protein expression. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
Harringtonine inhibits protein synthesis by preventing the initial elongation step of translation, which could suppress protein production. | ||||||
Harringtonin | 26833-85-2 | sc-204771 sc-204771A sc-204771B sc-204771C sc-204771D | 5 mg 10 mg 25 mg 50 mg 100 mg | $195.00 $350.00 $475.00 $600.00 $899.00 | 30 | |
Homoharringtonine inhibits protein synthesis by blocking the binding of aminoacyl-tRNA to the ribosome, potentially reducing protein expression. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $360.00 $475.00 | 20 | |
Blasticidin S inhibits protein synthesis by causing the misreading of mRNA, which can prevent the normal expression of proteins. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $352.00 $566.00 $1331.00 $2453.00 | ||
Emetine inhibits protein synthesis by binding to the 40S ribosomal subunit, blocking the translocation of peptides. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which can be critical for the stability and function of some proteins, potentially reducing their expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts protein transport by inhibiting the exchange of GDP for GTP on ADP-ribosylation factors, which can lead to a reduction in protein expression. | ||||||